Ionis Pharmaceuticals Inc
NASDAQ:IONS

Watchlist Manager
Ionis Pharmaceuticals Inc Logo
Ionis Pharmaceuticals Inc
NASDAQ:IONS
Watchlist
Price: 37.31 USD -0.82% Market Closed
Updated: May 18, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

2.8B
-8%
Assets
Growth Rates:
1 Year
-4%
3 Years
+23%
5 Years
-3%
7 Years
+155%
10 Years
+231%
2.5B
-5%
Liabilities
Growth Rates:
1 Year
+3%
3 Years
+57%
5 Years
+52%
7 Years
+180%
10 Years
+436%
296.5m
-23%
Equity
Growth Rates:
1 Year
-39%
3 Years
-56%
5 Years
-75%
7 Years
+47%
10 Years
-21%

Balance Sheet Decomposition
Ionis Pharmaceuticals Inc

2.8B
Assets
2.5B
Liabilities
2.8B
Assets
2.5B
Liabilities
Current Assets 2.4B
Cash & Short-Term Investments 2.2B
Receivables 5.1m
Other Current Assets 204.3m
Non-Current Assets 348.3m
PP&E 242.2m
Other Non-Current Assets 106m
Current Liabilities 327.6m
Accounts Payable 13.1m
Accrued Liabilities 127.6m
Other Current Liabilities 187m
Non-Current Liabilities 2.1B
Long-Term Debt 1.2B
Other Non-Current Liabilities 908.8m

Balance Sheet
Ionis Pharmaceuticals Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
143
129
85
130
279
683
398
869
277
2 331
Cash Equivalents
143
129
85
130
279
683
398
869
277
2 331
Short-Term Investments
668
675
583
893
1 805
1 816
1 495
1 246
1 710
1 932
Total Receivables
4
11
108
63
13
63
76
62
26
98
Accounts Receivables
4
11
108
63
13
63
76
62
26
98
Other Receivables
0
0
0
0
0
0
0
0
0
0
Inventory
6
7
8
10
9
18
22
25
22
28
Other Current Assets
16
15
15
73
103
140
140
143
168
184
Total Current Assets
837
837
798
1 169
2 208
2 721
2 131
2 345
2 203
2 642
PP&E Net
89
90
93
122
132
166
181
196
256
243
PP&E Gross
89
0
93
122
132
166
0
196
256
243
Accumulated Depreciation
66
0
80
88
62
74
0
103
88
97
Intangible Assets
20
19
20
22
24
26
28
29
0
0
Other Long-Term Assets
10
1
1
10
304
321
50
42
75
105
Total Assets
956
N/A
948
-1%
913
-4%
1 323
+45%
2 668
+102%
3 233
+21%
2 390
-26%
2 612
+9%
2 534
-3%
2 990
+18%
Liabilities
Accounts Payable
18
28
21
25
29
16
17
12
18
26
Accrued Liabilities
43
44
60
92
78
106
156
130
197
224
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
9
1
2
14
0
316
1
0
44
Other Current Liabilities
52
67
51
125
160
151
110
98
97
154
Total Current Liabilities
115
149
134
244
280
273
599
241
312
448
Long-Term Debt
455
464
588
606
633
770
624
1 228
1 183
1 230
Minority Interest
0
0
0
84
139
214
0
0
0
0
Other Liabilities
128
134
91
108
567
505
424
371
467
926
Total Liabilities
698
N/A
747
+7%
813
+9%
1 042
+28%
1 620
+55%
1 762
+9%
1 647
-7%
1 840
+12%
1 961
+7%
2 603
+33%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
1 007
1 095
1 181
1 241
967
708
1 131
1 160
1 430
1 796
Additional Paid In Capital
1 225
1 309
1 311
1 554
2 047
2 204
1 896
1 964
2 060
2 215
Other Equity
40
14
30
32
32
25
21
33
58
33
Total Equity
258
N/A
201
-22%
100
-50%
281
+182%
1 048
+273%
1 471
+40%
743
-49%
772
+4%
573
-26%
387
-33%
Total Liabilities & Equity
956
N/A
948
-1%
913
-4%
1 323
+45%
2 668
+102%
3 233
+21%
2 390
-26%
2 612
+9%
2 534
-3%
2 990
+18%
Shares Outstanding
Common Shares Outstanding
118
120
122
125
138
140
140
141
142
144

See Also

Summary
IONS intrinsic value, competitors valuation, and company profile.
DCF Valuation
IONS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IONS stock valuation using valuation multiples.
Wall Street Estimates
IONS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IONS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.